fluoropyrimidine, HER2-wanaagsan, oxaliplatin, Seagen Inc, tucatinib, Tukysa
Oggolaanshaha degdega ah waxaa siisa FDA si ay u siiso tucatinib leh trastuzumab kansarka mindhicirka
Bishii Febraayo 2023, Maamulka Cuntada iyo Dawooyinka (FDA) ayaa dardar galiyay oggolaanshaha tucatinib (Tukisa, Seagen Inc.) iyo trastuzumab ee daawaynta RAS-nooca duurjoogta ah ee HER2-positive kansarka mindhicirka oo faafay ama aan noqon karin rem.
Adcetris, brentuximab vedotin, lymphoma classical Hodgkin, Seagen Inc
Brentuximab vedotin waxaa ansixisay FDA iyadoo lagu daray kiimoterabiga loogu talagalay bukaannada carruurta ee qaba lymphoma Hodgkin classical
Noofembar 2022: Isku darka doxorubicin, vincristine, etoposide, prednisone, iyo cyclophosphamide oo leh brentuximab vedotin (Adcetris, Seagen, Inc.) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka si loogu isticmaalo carruurta